Back
Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
78
GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF
Last Price:
$132.59
Seasonality Move:
3.87%
Sell
32
NONOF
Novo Nordisk A/S
Last Price:
$48.00
Seasonality Move:
3.42%
Buy
78
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC)
is a Buy
Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?
-
The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $132.56. The Score for GSLC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
GSLC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $48.00. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GSLC Stock Price Chart
What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?
-
The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $132.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GSLC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $48.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
GSLC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 55.09 | Buy |
| Chaikin Money Flow: | 136561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (129.1 - 133.06) | Buy |
| Bollinger Bands (100): | (126.51 - 131.89) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 47.42 | Sell |
| Chaikin Money Flow: | 54114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.71 - 49.05) | Buy |
| Bollinger Bands (100): | (47.98 - 57.06) | Sell |
GSLC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.26 | Buy |
| 20-day SMA: | 131.82 | Buy |
| 50-day SMA: | 130.89 | Buy |
| 200-day SMA: | 121.79 | Buy |
| 8-day EMA: | 132.01 | Buy |
| 20-day EMA: | 131.74 | Buy |
| 50-day EMA: | 128.69 | Buy |
| 200-day EMA: | 82.51 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.81 | Sell |
| 20-day SMA: | 47.97 | Buy |
| 50-day SMA: | 50.02 | Sell |
| 200-day SMA: | 60.74 | Sell |
| 8-day EMA: | 48.35 | Sell |
| 20-day EMA: | 48.4 | Sell |
| 50-day EMA: | 50.13 | Sell |
| 200-day EMA: | 63 | Sell |
Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||